{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T04:59:44Z","timestamp":1758862784638,"version":"3.37.3"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T00:00:00Z","timestamp":1542672000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001922","name":"Efficacy and Mechanism Evaluation Programme","doi-asserted-by":"publisher","award":["14\/150\/03"],"award-info":[{"award-number":["14\/150\/03"]}],"id":[{"id":"10.13039\/501100001922","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13063-018-3008-6","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T09:24:44Z","timestamp":1542705884000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A multi-centre, double-blind, placebo-controlled, randomised trial of combination methotrexate and gefitinib versus methotrexate alone to treat tubal ectopic pregnancies (GEM3): trial protocol"],"prefix":"10.1186","volume":"19","author":[{"given":"James","family":"May","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Mol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siladitya","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arri","family":"Coomarasamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davor","family":"Jurkovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Bourne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Bottomley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Peace-Gadsby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Doust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew W.","family":"Horne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,20]]},"reference":[{"issue":"Suppl 1","key":"3008_CR1","first-page":"1","volume":"118","author":"R Cantwell","year":"2011","unstructured":"Cantwell R, Clutton-Brock T, Cooper G, Dawson A, Drife J, Garrod D, Harper A, Hulbert D, Lucas S, McClure J, et al. Saving mothers' lives: reviewing maternal deaths to make motherhood safer: 2006-2008. The eighth report of the confidential enquiries into maternal deaths in the United Kingdom. BJOG. 2011;118(Suppl 1):1\u2013203.","journal-title":"BJOG"},{"issue":"6","key":"3008_CR2","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","volume":"2","author":"L Say","year":"2014","unstructured":"Say L, Chou D, Gemmill A, Tuncalp O, Moller AB, Daniels J, Gulmezoglu AM, Temmerman M, Alkema L. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):e323\u201333.","journal-title":"Lancet Glob Health"},{"key":"3008_CR3","unstructured":"Ectopic pregnancy and miscarriage: diagnosis and initial management in early pregnancy for ectopic pregnancy and miscarriage (clinical guideline 154) [\n                    http:\/\/www.nice.org.uk\/CG154\n                    \n                  ]. Accessed 12 Nov 2018."},{"issue":"1","key":"3008_CR4","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/uog.12401","volume":"42","author":"D Mavrelos","year":"2013","unstructured":"Mavrelos D, Nicks H, Jamil A, Hoo W, Jauniaux E, Jurkovic D. Efficacy and safety of a clinical protocol for expectant management of selected women diagnosed with a tubal ectopic pregnancy. Ultrasound Obstet Gynecol. 2013;42(1):102\u20137.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"3008_CR5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/humrep\/des373","volume":"28","author":"NM van Mello","year":"2013","unstructured":"van Mello NM, Mol F, Verhoeve HR, van Wely M, Adriaanse AH, Boss EA, Dijkman AB, Bayram N, Emanuel MH, Friederich J, et al. Methotrexate or expectant management in women with an ectopic pregnancy or pregnancy of unknown location and low serum hCG concentrations? A randomized comparison. Hum Reprod. 2013;28(1):60\u20137.","journal-title":"Hum Reprod"},{"issue":"12","key":"3008_CR6","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/nrc1506","volume":"4","author":"RS Herbst","year":"2004","unstructured":"Herbst RS, Fukuoka M, Baselga J. Gefitinib\u2014a novel targeted approach to treating cancer. Nat Rev Cancer. 2004;4(12):956\u201365.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"3008_CR7","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1097\/AOG.0b013e3182a1ba56","volume":"122","author":"UW Nilsson","year":"2013","unstructured":"Nilsson UW, Johns TG, Wilmann T, Kaitu'u-Lino T, Whitehead C, Dimitriadis E, Menkhorst E, Saglam B, Gao Y, Greenall SA, et al. Effects of gefitinib, an epidermal growth factor receptor inhibitor, on human placental cell growth. Obstet Gynecol. 2013;122(4):737\u201344.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"3008_CR8","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1097\/AOG.0b013e3182a14cfb","volume":"122","author":"MM Skubisz","year":"2013","unstructured":"Skubisz MM, Horne AW, Johns TG, Nilsson UW, Duncan WC, Wallace EM, Critchley HO, Tong S. Combination gefitinib and methotrexate compared with methotrexate alone to treat ectopic pregnancy. Obstet Gynecol. 2013;122(4):745\u201351.","journal-title":"Obstet Gynecol"},{"issue":"7","key":"3008_CR9","doi-asserted-by":"publisher","first-page":"e002902","DOI":"10.1136\/bmjopen-2013-002902","volume":"3","author":"Andrew W Horne","year":"2013","unstructured":"Horne AW, Skubisz MM, Doust A, Duncan WC, Wallace E, Critchley HO, Johns TG, Norman JE, Bhattacharya S, Mollison J, et al. Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of a combination of gefitinib and methotrexate to treat tubal ectopic pregnancies (GEM II): study protocol. BMJ Open. 2013;3(7).","journal-title":"BMJ Open"},{"key":"3008_CR10","unstructured":"Skubisz MMTS, Doust A, Mollison J, Johns TG, Neil P, Robinson M, Bhattacharya S, Wallace E, Krzys N, Duncan WC, Horne AW. Gefitinib and methotrexate to treat ectopic pregnancies with a pre-treatment serum hCG 1000\u201310,000 IU\/L: phase II open label, single arm multi-centre trial. EBioMedicine. In Press."},{"issue":"4","key":"3008_CR11","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1158\/1078-0432.CCR-03-0564","volume":"10","author":"MH Cohen","year":"2004","unstructured":"Cohen MH, Williams GA, Sridhara R, Chen G, McGuinn WD Jr, Morse D, Abraham S, Rahman A, Liang C, Lostritto R, et al. United States Food and Drug Administration drug approval summary: gefitinib (ZD1839; Iressa) tablets. Clin Cancer Res. 2004;10(4):1212\u20138.","journal-title":"Clin Cancer Res"},{"key":"3008_CR12","doi-asserted-by":"crossref","unstructured":"Skubisz MM, Tong S, Doust A, Mollison J, Johns TG, Neil P, Robinson M, Bhattacharya S, Wallace E, Krzys N, Colin Duncan W, Horne AW. Gefitinib and Methotrexate to Treat Ectopic Pregnancies with a Pre-Treatment Serum hCG 1000-10,000 IU\/L: Phase II Open Label, Single Arm Multi-Centre Trial.m EBioMedicine. 2018;33:276\u201381.","DOI":"10.1016\/j.ebiom.2018.06.017"},{"key":"3008_CR13","doi-asserted-by":"publisher","first-page":"423708","DOI":"10.1155\/2014\/423708","volume":"2014","author":"SN Avcioglu","year":"2014","unstructured":"Avcioglu SN, Altinkaya SO, Kucuk M, Demircan Sezer S, Yuksel H. Predictors of success of different treatment modalities for management of ectopic pregnancy. Obstet Gynecol Int. 2014;2014:423708.","journal-title":"Obstet Gynecol Int"},{"key":"3008_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1471-2393-13-30","volume":"13","author":"M Skubisz","year":"2013","unstructured":"Skubisz M, Dutton P, Duncan WC, Horne AW, Tong S. Using a decline in serum hCG between days 0-4 to predict ectopic pregnancy treatment success after single-dose methotrexate: a retrospective cohort study. BMC Pregnancy Childbirth. 2013;13:30.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"4","key":"3008_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/humupd\/dmn012","volume":"14","author":"F Mol","year":"2008","unstructured":"Mol F, Mol BW, Ankum WM, van der Veen F, Hajenius PJ. Current evidence on surgery, systemic methotrexate and expectant management in the treatment of tubal ectopic pregnancy: a systematic review and meta-analysis. Hum Reprod Update. 2008;14(4):309\u201319.","journal-title":"Hum Reprod Update"},{"issue":"12","key":"3008_CR16","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.3109\/00016340903188912","volume":"88","author":"LB Krag Moeller","year":"2009","unstructured":"Krag Moeller LB, Moeller C, Thomsen SG, Andersen LF, Lundvall L, Lidegaard O, Kjer JJ, Ingemanssen JL, Zobbe V, Floridon C, et al. Success and spontaneous pregnancy rates following systemic methotrexate versus laparoscopic surgery for tubal pregnancies: a randomized trial. Acta Obstet Gynecol Scand. 2009;88(12):1331\u20137.","journal-title":"Acta Obstet Gynecol Scand"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-3008-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-018-3008-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-3008-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T20:18:42Z","timestamp":1574194722000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-018-3008-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,20]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3008"],"URL":"https:\/\/doi.org\/10.1186\/s13063-018-3008-6","relation":{},"ISSN":["1745-6215"],"issn-type":[{"type":"electronic","value":"1745-6215"}],"subject":[],"published":{"date-parts":[[2018,11,20]]},"assertion":[{"value":"24 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was obtained from the Scotland A Research Ethics Committee (16\/SS\/0014) on 29 February 2016. Data will be presented at international conferences and published in peer-reviewed journals. We will make the information available to the public through national bodies and charities, e.g. the Ectopic Pregnancy Trust.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"ST holds a patent that relates to the use of gefitinib to treat ectopic pregnancies. BM is supported by a NHMRC Practitioner Fellowship (GNT1082548). BWM reports consultancy for ObsEva, Merck KGaA, and Guerbet. CB is on the advisory panel for Clearblue, was Scientific Chair of the Association of Early Pregnancy Units 2015\u20132017, and is a Medical Advisor to the Ectopic Pregnancy Trust. TB receives departmental research support from Roche Diagnostics and Samsung Medison. AWH is on the Scientific Board of the Association of Early Pregnancy Units, and is a Trustee and Medical Advisor to the Ectopic Pregnancy Trust. The remaining authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"643"}}